1. Agarwal V, Bajpai M, Sharma A (2018) Patented and approval scenario of nanopharmaceuticals with relevancy to biomedical application, manufacturing procedure and safety aspects. Recent Pat Drug Deliv Formul 12:40–52
2. Buzea C, Blandino IIP, Robbie K (2007) Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2(4):MR17
3. Cuffari B (2018) What nanomaterials exist in nature? AZoNano.
https://www.azonano.com/article.aspx?ArticleID=4837
4. Desai PP, Rustomjee MT (2016) Business Potential of Advanced Drug Delivery Systems. CRS Indian Local Chapter Newsletter 8:29–34. Retrieved from
https://www.google.com/url?sa=t&source=web&rct=j&url=http://www.crsic.org/pdf/newsletter- 2016.pdf&ved=2ahUKEwiI1IeN6fXoAhVY83MBHda6CdoQFjAAegQIARAB&usg=AOvVaw2a_GUGoJsDYEfOnnWCn7TV
5. Ealias AM, Saravanakumar MP (2017) A review on the classification, characterisation, synthesis of nanoparticles and their application. IOP Conf Ser Mater Sci Eng 263:1–15